These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17047209)

  • 21. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.
    Siontis GC; Stefanini GG; Mavridis D; Siontis KC; Alfonso F; Pérez-Vizcayno MJ; Byrne RA; Kastrati A; Meier B; Salanti G; Jüni P; Windecker S
    Lancet; 2015 Aug; 386(9994):655-64. PubMed ID: 26334160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirolimus-eluting stents: the novel application of basic science to coronary artery disease.
    Foley DP
    Ir Med J; 2002 Oct; 95(9):283. PubMed ID: 12470008
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement.
    Neumann FJ; Desmet W; Grube E; Brachmann J; Presbitero P; Rubartelli P; Mügge A; Di Pede F; Füllgraf D; Aengevaeren W; Spedicato L; Popma JJ
    Circulation; 2005 Apr; 111(16):2107-11. PubMed ID: 15851617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of drug-eluting stents.
    Med Lett Drugs Ther; 2012 Dec; 54(1406):102-3. PubMed ID: 23282791
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-eluting stents and other anti-restenosis devices].
    Moreno R
    Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent thrombosis in randomized clinical trials of drug-eluting stents.
    Mauri L; Hsieh WH; Massaro JM; Ho KK; D'Agostino R; Cutlip DE
    N Engl J Med; 2007 Mar; 356(10):1020-9. PubMed ID: 17296821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-eluting stents.
    Whitlow P
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):2S-6S. PubMed ID: 23573564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic rapamycin to prevent restenosis: a glimpse to the past?
    Belardi J
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):326. PubMed ID: 20162697
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioactive stents: problems and potential solutions].
    Hehrlein C
    Herz; 2002 Feb; 27(1):17-22. PubMed ID: 11951792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
    Gil RJ
    Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
    [No Abstract]   [Full Text] [Related]  

  • 31. Economic evaluation of sirolimus-eluting stents.
    Shrive FM; Manns BJ; Galbraith PD; Knudtson ML; Ghali WA;
    CMAJ; 2005 Feb; 172(3):345-51. PubMed ID: 15684117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stenting small coronary arteries: works in progress.
    Holmes DR
    JAMA; 2004 Dec; 292(22):2777-8. PubMed ID: 15585739
    [No Abstract]   [Full Text] [Related]  

  • 33. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug-eluting stents: do they keep their promises?].
    Nordmann A
    Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    Scheller B; Ong PJ; Kleber F
    J Am Coll Cardiol; 2016 Jan; 67(3):346-7. PubMed ID: 26796403
    [No Abstract]   [Full Text] [Related]  

  • 36. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
    Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.
    Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Mantilla R; Morís C; Cequier A; Sabaté M; Escaned J; Moreno R; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2152-60. PubMed ID: 16750678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution?
    Rodriguez AE; Waksman R
    JACC Cardiovasc Interv; 2009 Jan; 2(1):75-6; author reply 76-7. PubMed ID: 19463404
    [No Abstract]   [Full Text] [Related]  

  • 39. "At least but not at last" equivalent!
    Bonan R
    Catheter Cardiovasc Interv; 2004 Jul; 62(3):289. PubMed ID: 15224290
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply: Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    Alfonso F; Pérez Vizcayno MJ; Cárdenas A; García Del Blanco B; García-Touchard A; López-Minguez JR
    J Am Coll Cardiol; 2016 Jan; 67(3):348-9. PubMed ID: 26796404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.